Home › Non-Muscle Invasive Bladder Cancer › Georgia
Non-Muscle Invasive Bladder Cancer clinical trials in Georgia
7 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Georgia.
Cities in Georgia
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Georgia Urology, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital, Atlanta
- Emory University, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07206225Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Urology of Greater Atlanta - Sandy Springs, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Emory University Hospital, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Emory University, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Emory University, Atlanta
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Mar 27, 2026 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- Emory University School of Medicine, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.